1. Development of a peptide-based delivery platform for targeting malignant brain tumors. (September 2020) Authors: Rahn, Jennifer J.; Lun, Xueqing; Jorch, Selina K.; Hao, Xiaoguang; Venugopal, Chitra; Vora, Parvez; Ahn, Bo Young; Babes, Liane; Alshehri, Mana M.; Cairncross, J. Gregory; Singh, Sheila K.; Kubes, Paul; Senger, Donna L.; Robbins, Stephen M. Journal: Biomaterials Issue: Volume 252(2020:Aug.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Double‐deleted vaccinia virus in virotherapy for refractory and metastatic pediatric solid tumors. Issue 5 (14th June 2013) Authors: Lun, Xueqing; Ruan, Yibing; Jayanthan, Aarthi; Liu, David J.; Singh, Anjali; Trippett, Tanya; Bell, John; Forsyth, Peter; Johnston, Randal N.; Narendran, Aru Journal: Molecular oncology Issue: Volume 7:Issue 5(2013:Oct.) Page Start: 944 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy. Issue 6 (12th November 2014) Authors: Ruan, Yibing; Kovalchuk, Anna; Jayanthan, Aarthi; Lun, Xueqing; Nagashima, Yoji; Kovalchuk, Olga; Wright, James R.; Pinto, Alfredo; Kirton, Adam; Anderson, Ronald; Narendran, Aru Journal: Neuro-oncology Issue: Volume 17:Issue 6(2015:Jun.) Page Start: 822 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastoma. Issue 8 (8th March 2016) Authors: Pisklakova, Alexandra; McKenzie, Brienne; Zemp, Franz; Lun, Xueqing; Kenchappa, Rajappa S.; Etame, Arnold B.; Rahman, Masmudur M.; Reilly, Karlyne; Pilon-Thomas, Shari; McFadden, Grant; Kurz, Ebba; Forsyth, Peter A. Journal: Neuro-oncology Issue: Volume 18:Issue 8(2016:Aug.) Page Start: 1088 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Profiling pathway‐specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): Favorable activity of targeting EGFR‐ ErbB2 signaling with lapatinib. Issue 3 (11th January 2013) Authors: Singh, Anjali; Lun, Xueqing; Jayanthan, Aarthi; Obaid, Halah; Ruan, Yibing; Strother, Douglas; Chi, Susan N.; Smith, Amy; Forsyth, Peter; Narendran, Aru Journal: Molecular oncology Issue: Volume 7:Issue 3(2013) Page Start: 497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. STEM-29. THE HISTONE VARIANT macroH2A2 ORCHESTRATES AN ACTIONABLE CHROMATIN PROGRAM OF STEMNESS IN GLIOBLASTOMA. (9th November 2020) Authors: Nikolic, Ana; Bobyn, Anna; Ellestad, Katrina; Lun, Xueqing; Johnston, Michael; Gafuik, Christopher; Zemp, Franz; Ninkovic, Nicoletta; Berger, Daniel; Brownsey, Duncan; Dirks, Peter; Derksen, Darren; Senger, Donna; Chan, Jennifer; Mahoney, Douglas; Gallo, Marco Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗